Nvidia's Jensen Huang warns inadequate energy and infrastructure may cost the US its tech advantage. That has some logic. But ...

A year of deregulation and renewed dealmaking fueled big paper gains for bank bosses, like JPMorgan head Jamie Dimon’s $566 ...

InPost, the e-commerce delivery group, said it had received an indicative acquisition proposal. Its shares rose 20% even ...

European leaders’ muted response to Donald Trump’s raid on Venezuela doesn’t augur well should the US president seize Denmark ...

The continent has finite resources and a 2,700 km front with its belligerent neighbour. Cheap sensors and unmanned aircraft ...

The benchmark index outpaced gains in China and Japan last year, but at 1.2 times book value it lags on valuation. A forceful ...

Australian and US firms SGH and Steel Dynamics are bidding $8.8 bln for Melbourne-based BlueScope, but like Nippon Steel’s US ...

Chevron and ConocoPhillips shares rose over 5% after Washington’s capture of Nicolas Maduro. But Venezuela’s risks will ...

China's BYD sold more than 2 mln EVs, overtaking its $1.4 trln US rival. As subsidies shrink and profit flags, the decision to focus on self-driving and batteries by the Cybertruck maker's frenetic ...

The world economy is making a surprising habit of shrugging off unpleasant shocks. Since 2020, the planet has weathered a global pandemic, inflation, sharply rising interest rates, and the outbreak of ...

The city hosted $37 bln of new share sales in 2025 after several lean years, helped by bumper first-day gains. The expectation is that demand for Chinese AI firms will keep the good times rolling. But ...

China is on a medically induced high. In 2025, homegrown biotech champions like 3SBio and CSPC Pharmaceutical struck dozens of deals to license drugs and technology to multinational giants such as ...